Neither platform integrates genetic pathway testing into routine assessment, but both collect metabolic and behavioral data that can inform personalized dosing and monitoring
Recent studies 58 have yielded conflicting results regarding the potential relationship between GLP-1 RAs and optic nerve pathologies, particularly non-arteritic anterior ischemic optic neuropathy (NAION)
It works by binding to ghrelin receptors in the brain, which stimulates the pituitary gland to release growth hormone (GH)
Herein, we report that pharmacologic activation of the cell GLP-1R induced cell PC1/3 and GLP-1 expression in mice
doi: 10.1056/NEJMoa1008862
There's also clinician preference and experience, and uh, they what they are comfortable working with and there's comorbid insulin resistance that also has to be considered in this conversation